Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02108938 · ClinicalTrials.gov registry record
Brain-Gut Interactions in Crohn's Disease
A clinical trial, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 25
- Enrollment target
NCT02108938: Completed study, sponsored by University of Wisconsin, Madison.
NCT02108938 is a clinical trial that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 25 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02108938 has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
Study Summary
The primary aims for this research are to 1) characterize brain changes in patients with CD compared to age and gender-matched controls and 2) relate these brain changes to measures of disease activity and pain severity.
Primary Outcome
Because of the relatively large number of predictor variables in relation to the potential number of subjects, these analyses will be considered exploratory and aimed at generating hypotheses. Future studies with a larger number of subjects can be focused on hypothesis-driven questions and in developing diagnostic brain-based biomarkers and determining whether novel treatments aimed at the brain-gut axis may alter disease activity and pain perception in this patient population.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2014-09-10 |
| Est. Completion | 2015-05-18 |
What the finished NCT02108938 record still lists
NCT02108938 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02108938 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02108938 about?
NCT02108938 is a clinical study titled "Brain-Gut Interactions in Crohn's Disease". The primary aims for this research are to 1) characterize brain changes in patients with CD compared to age and gender-matched controls and 2) relate these brain changes to measures of disease activity and pain severity.
What is the current status of trial NCT02108938?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2014-09-10. Estimated completion is 2015-05-18.
Who is sponsoring clinical trial NCT02108938?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI